The Medical Device Business Journal — Medical Device News & Articles | MassDevice
The $2.3 billion awarded to St. Jude Medical Inc. (NYSE:STJ) by a jury over a trade secret theft trial was pared back by the judge overseeing the case, leaving St. Jude with just under $1 billion and a wide-ranging injunction against former employee Yongning Zou.
Zou was accused of using his access to highly confidential information to swipe details on STJ-branded pacemakers, defibrillators and neuromodulators and found Nervicon Co. Ltd. in China.
St. Jude Medical Inc. (NYSE:STJ) won a whopping $2.3 billion award from a California jury that found a former engineer culpable of using stolen trade secrets to start a competing company in China — adding nearly a billion dollars to what St. Jude sought.
It only took two hours for the Los Angeles Superior Court jury to find that Yongning Zou, an engineer with St. Jude subsidiary Pacesetter Inc., used his access to confidential company information to found Nervicon Co. Ltd. in China.
